TYMS POLYMORPHISMS AND METHOTREXATE THERAPEUTIC OUTCOME IN RHEUMATOID ARTHRITIS PORTUGUESE PATIENTS: ANALYSIS OF KEY POLYMORPHISMS

被引：0
|
作者：
Lima, A. [1 ,2 ,3 ]
Seabra, V. [1 ]
Bernardes, M. [4 ]
Azevedo, A. R. [5 ]
Sousa, H. [5 ]
Medeiros, R. [5 ]
机构：
[1] Gandra PRD, Inst Res & Adv Training Hlth Sci & Technol, Higher Inst Hlth Sci ISCS N, Dept Pharmaceut Sci,IINFACTS CESPU, Oporto, Portugal
[2] Univ Porto, Abel Salazar Inst Biomed Sci ICBAS, P-4100 Oporto, Portugal
[3] Portuguese Inst Oncol Porto IPO Porto, CI, Mol Oncol Grp, Oporto, Portugal
[4] Sao Joao Hosp Ctr, Rheumatol Dept, Oporto, Portugal
[5] Portuguese Inst Oncol Porto IPO Porto, Mol Oncol Grp CI, Oporto, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4672
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0457
引用
收藏
页码：341 / 341
页数：1
相关论文
共 50 条
  • [31] Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis
    Hayashi, H.
    Fujimaki, C.
    Daimon, T.
    Tsuboi, S.
    Matsuyama, T.
    Itoh, K.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (03) : 355 - 361
  • [32] Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate: reply
    Lee, Yvonne C.
    Cui, Jing
    Costenbader, Karen H.
    Shadick, Nancy A.
    Weinblatt, Michael E.
    Karlson, Elizabeth W.
    RHEUMATOLOGY, 2009, 48 (09) : 1177 - 1177
  • [33] Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
    Grabar, Petra Bohanec
    Rojko, Sabina
    Logar, Dusan
    Dolzan, Vita
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (05) : 931 - U186
  • [34] DISCONTINUATION OF METHOTREXATE TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RELATIOMSHIPS WITH CANDIDATE SINGLE NUCLEOTIDE POLYMORPHISMS
    Soukup, T.
    Dosedel, M.
    Pavek, P.
    Nekvindova, J.
    Kubena, A. A.
    Barvik, I.
    Vicek, J.
    Bradna, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1070 - 1070
  • [35] Usefulness of Cytokine Gene Polymorphisms for the Therapeutic Choice in Japanese Patients with Rheumatoid Arthritis
    Tsujimoto, Saki
    Ozaki, Yoshio
    Ito, Tomoki
    Nomura, Shosaku
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 131 - 139
  • [36] Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis
    Chen, Yuehong
    Zou, Kun
    Sun, Jianhong
    Yang, Yuan
    Liu, Gang
    PHARMACOGENOMICS, 2017, 18 (02) : 175 - 195
  • [37] Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism
    Grabar, Petra Bohanec
    Logar, Dusan
    Lestan, Boris
    Dolzan, Vita
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (11) : 1057 - 1068
  • [38] Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism
    Petra Bohanec Grabar
    Dušan Logar
    Boris Lestan
    Vita Dolžan
    European Journal of Clinical Pharmacology, 2008, 64 : 1057 - 1068
  • [39] Interleukin gene polymorphisms in patients with rheumatoid arthritis
    Leon, V. J.
    Leon, A. J.
    Hernandez-Cerceno, M.
    TISSUE ANTIGENS, 2007, 69 (05): : 469 - 470
  • [40] Clinical and Laboratory Associations with Methotrexate Metabolism Gene Polymorphisms in Rheumatoid Arthritis
    D'Cruz, Leon G.
    McEleney, Kevin G.
    Tan, Kyle B. C.
    Shukla, Priyank
    Gardiner, Philip V.
    Connolly, Patricia
    Conway, Caroline
    Cobice, Diego
    Gibson, David S.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 14
12345